These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 33833274)
1. Gene expression profiles of YAP1, TAZ, CRB3, and VDR in familial and sporadic multiple sclerosis among an Iranian population. Khalilian S; Hojati Z; Dehghanian F; Shaygannejad V; Imani SZH; Kheirollahi M; Khorrami M; Mirmosayyeb O Sci Rep; 2021 Apr; 11(1):7713. PubMed ID: 33833274 [TBL] [Abstract][Full Text] [Related]
2. Expression and clinical significance of IL7R, NFATc2, and RNF213 in familial and sporadic multiple sclerosis. Imani SZH; Hojati Z; Khalilian S; Dehghanian F; Kheirollahi M; Khorrami M; Shaygannejad V; Mirmosayyeb O Sci Rep; 2021 Sep; 11(1):19260. PubMed ID: 34584155 [TBL] [Abstract][Full Text] [Related]
3. Clinical and diagnostic features of patients with familial multiple sclerosis. Andrijauskis D; Balnyte R; Keturkaite I; Vaitkus A Med Hypotheses; 2019 Oct; 131():109310. PubMed ID: 31443766 [TBL] [Abstract][Full Text] [Related]
4. Hippo-YAP1 signaling pathway and severe preeclampsia (sPE) in the Chinese population. Liu R; Wei C; Ma Q; Wang W Pregnancy Hypertens; 2020 Jan; 19():1-10. PubMed ID: 31841877 [TBL] [Abstract][Full Text] [Related]
5. Familial multiple sclerosis patients have a shorter delay in diagnosis than sporadic cases. Steenhof M; Stenager E; Nielsen NM; Kyvik K; Möller S; Hertz JM Mult Scler Relat Disord; 2019 Jul; 32():97-102. PubMed ID: 31078918 [TBL] [Abstract][Full Text] [Related]
6. Familial multiple sclerosis in Greece: Distinct clinical and imaging characteristics in comparison with the sporadic disease. Katsavos S; Artemiadis A; Davaki P; Stamboulis E; Kilindireas K; Anagnostouli M Clin Neurol Neurosurg; 2018 Oct; 173():144-149. PubMed ID: 30125837 [TBL] [Abstract][Full Text] [Related]
7. Differential expression of STAT3 gene and its regulatory long non-coding RNAs, namely lnc-DC and THRIL, in two eastern Iranian ethnicities with multiple sclerosis. Pahlevan Kakhki M; Rakhshi N; Emami Aleagha MS; Abdari M; Alikhah A; Safarian G; Behmanesh M; Nikravesh A Neurol Sci; 2020 Mar; 41(3):561-568. PubMed ID: 31713760 [TBL] [Abstract][Full Text] [Related]
8. MRI but not demographic or clinical characteristics differ between familial and sporadic MS cases. Moghadam NB; Ghaffari M; Rashed SS; Valaie N; Hesami O; Niloofar P; Ghazanfari Y Mult Scler Relat Disord; 2021 Nov; 56():103235. PubMed ID: 34678703 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology of familial multiple sclerosis and its comparison to sporadic form in Markazi Province, Iran. Faraji F; Mohaghegh P; Talaie A Mult Scler Relat Disord; 2022 Dec; 68():104231. PubMed ID: 36270251 [TBL] [Abstract][Full Text] [Related]
10. A comparison of sporadic and familial multiple sclerosis. Weinshenker BG; Bulman D; Carriere W; Baskerville J; Ebers GC Neurology; 1990 Sep; 40(9):1354-8. PubMed ID: 2392217 [TBL] [Abstract][Full Text] [Related]
11. Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma. Rodríguez-Núñez P; Romero-Pérez L; Amaral AT; Puerto-Camacho P; Jordán C; Marcilla D; Grünewald TG; Alonso J; de Alava E; Díaz-Martín J J Pathol; 2020 Apr; 250(4):374-386. PubMed ID: 31880317 [TBL] [Abstract][Full Text] [Related]
12. MRI characteristics of familial and sporadic multiple sclerosis patients. Tipirneni A; Weinstock-Guttman B; Ramanathan M; Abdelrahman N; Hussein S; Hagemeier J; Durfee J; Teter BE; Hojnacki D; Dwyer MG; Zivadinov R Mult Scler; 2013 Aug; 19(9):1145-52. PubMed ID: 23232600 [TBL] [Abstract][Full Text] [Related]
13. Imaging brain damage in first-degree relatives of sporadic and familial multiple sclerosis. De Stefano N; Cocco E; Lai M; Battaglini M; Spissu A; Marchi P; Floris G; Mortilla M; Stromillo ML; Paolillo A; Federico A; Marrosu MG Ann Neurol; 2006 Apr; 59(4):634-9. PubMed ID: 16498621 [TBL] [Abstract][Full Text] [Related]
14. Proton magnetic resonance spectroscopy of normal appearing white matter in familial and sporadic multiple sclerosis. Siger-Zajdel M; Selmaj KW J Neurol; 2005 Jul; 252(7):830-2. PubMed ID: 15772740 [TBL] [Abstract][Full Text] [Related]
15. Effects of the hippo signaling pathway in human gastric cancer. Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801 [TBL] [Abstract][Full Text] [Related]
16. Investigation of ERG Gene Expression in Iranian Patients with Multiple Sclerosis. Yazdanpanahi N; Etemadifar M; Kardi MT; Shams E; Shahbazi S Immunol Invest; 2018 May; 47(4):351-359. PubMed ID: 29488813 [TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis and subclinical neuropathology in healthy individuals with familial risk: A scoping review of MRI studies. Mortazavi M; Hizarci Ö; Gerdes LA; Havla J; Kümpfel T; Hohlfeld R; Stöcklein S; Keeser D; Ertl-Wagner B Neuroimage Clin; 2021; 31():102734. PubMed ID: 34171607 [TBL] [Abstract][Full Text] [Related]
19. Molecular Mechanism of Hippo-YAP1/TAZ Pathway in Heart Development, Disease, and Regeneration. Chen X; Li Y; Luo J; Hou N Front Physiol; 2020; 11():389. PubMed ID: 32390875 [TBL] [Abstract][Full Text] [Related]
20. Distribution of disease courses in familial vs sporadic multiple sclerosis. Steenhof M; Nielsen NM; Stenager E; Kyvik K; Möller S; Hertz JM Acta Neurol Scand; 2019 Mar; 139(3):231-237. PubMed ID: 30412642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]